Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · Real-Time Price · USD
2.075
-0.075 (-3.49%)
Aug 28, 2026, 12:05 PM EDT - Market open
Acrivon Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Buy Maintains $7 | Buy | Maintains | $7 | +237.35% | Aug 14, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $8 | Buy | Maintains | $8 | +285.54% | Aug 13, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $8 | Buy | Reiterates | $8 | +285.54% | Aug 13, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $19 | Buy | Maintains | $19 | +815.66% | Aug 13, 2026 |
Jeff Jonas Gabelli No rating | Gabelli | Buy Initiates $8 | Buy | Initiates | $8 | +285.54% | Jun 15, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 14, 2026 |
Unknown Analyst Jefferies No rating | Jefferies | Buy Maintains $14 | Buy | Maintains | $14 | +574.70% | Mar 20, 2026 |